CAP Addictions Professional Core Knowledge and Competencies 2 — Questions and Answers
Question 1: Which neurotransmitter system is primarily implicated in the reinforcing effects of most addictive substances?
- Serotonin
- Dopamine (Correct answer)
- GABA
- Acetylcholine
Correct answer: Dopamine
Dopamine release in the mesolimbic pathway (nucleus accumbens) is the primary neurobiological mechanism underlying the rewarding effects of addictive substances.
Question 2: A client describes using alcohol every evening to 'unwind' and reports irritability when unable to drink. This pattern BEST reflects which stage of the addiction cycle?
- Binge/intoxication
- Withdrawal/negative affect (Correct answer)
- Preoccupation/anticipation
- Tolerance development
Correct answer: Withdrawal/negative affect
The withdrawal/negative affect stage is characterized by dysphoria and irritability when the substance is unavailable, driving use to relieve these negative states.
Question 3: According to the ASAM criteria, which dimension addresses a client's ability to manage daily responsibilities and cope with life stressors without substance use?
- Dimension 3: Emotional, Behavioral, or Cognitive Conditions
- Dimension 5: Relapse, Continued Use, or Continued Problem Potential (Correct answer)
- Dimension 6: Recovery/Living Environment
- Dimension 4: Readiness to Change
Correct answer: Dimension 5: Relapse, Continued Use, or Continued Problem Potential
ASAM Dimension 5 evaluates the client's risk of relapse or continued use and their coping skills for managing stressors without substances.
Question 4: Which principle of motivational interviewing involves the counselor summarizing the client's ambivalence about change to reinforce change talk?
- Expressing empathy
- Rolling with resistance
- Developing discrepancy (Correct answer)
- Supporting self-efficacy
Correct answer: Developing discrepancy
Developing discrepancy helps clients recognize the gap between their current behavior and their personal values or goals, amplifying motivation for change.
Question 5: A co-occurring diagnosis of major depressive disorder and alcohol use disorder is BEST described as:
- A contraindication to SUD treatment
- A dual diagnosis requiring integrated treatment (Correct answer)
- A secondary condition to be addressed after sobriety
- A misdiagnosis since symptoms overlap
Correct answer: A dual diagnosis requiring integrated treatment
Dual diagnosis (co-occurring disorders) is best treated with an integrated approach that addresses both conditions simultaneously rather than sequentially.
Question 6: Which medication is FDA-approved for reducing cravings and the rewarding effects of alcohol in alcohol use disorder?
- Disulfiram
- Naltrexone (Correct answer)
- Acamprosate
- Buprenorphine
Correct answer: Naltrexone
Naltrexone is an opioid antagonist that blocks the euphoric effects of alcohol and reduces cravings by blocking opioid receptors involved in alcohol reward.
Question 7: The concept of 'geographic cure' in addiction refers to:
- Using travel therapy as a treatment modality
- Believing that changing location will resolve addiction (Correct answer)
- A relapse prevention technique involving environmental changes
- Moving clients to sober living environments
Correct answer: Believing that changing location will resolve addiction
Geographic cure is a maladaptive belief that physical relocation will eliminate addiction, when in fact internal psychological factors travel with the individual.
Which neurotransmitter system is primarily implicated in the reinforcing effects of most addictive substances?